LOADING
Comparing Microsoft Corporation (MSFT) and Johnson & Johnson (JNJ) across the Technology and Health Care sectors. This side-by-side analysis covers price, valuation multiples, profitability, growth, dividends, and risk metrics to help investors evaluate these two stocks.
| Metric | MSFT | JNJ |
|---|---|---|
| Price | -- | -- |
| Change Today | +0.00% | +0.00% |
| Market Cap | $3.45T | $617.8B |
| P/E Ratio | 25.9 | 29.8 |
| Forward P/E | 23.6 | 22.0 |
| PEG Ratio | 1.52 | 4.23 |
| EPS | $17.94 | $8.61 |
| Revenue Growth (YoY) | 17.7% | 6.6% |
| Profit Margin | 40.3% | 21.5% |
| Return on Equity | 34.0% | 25.7% |
| Dividend Yield | 0.81% | 2.05% |
| Beta | 1.13 | 0.23 |
| 52-Week High | $550.24 | $274.90 |
| 52-Week Low | $349.20 | $165.50 |
| Volume | -- | -- |
Microsoft Corporation is the larger company by market capitalization. Microsoft Corporation trades at a lower P/E ratio, suggesting it may offer better value relative to earnings. Johnson & Johnson offers a higher dividend yield for income investors. Microsoft Corporation has stronger profit margins. Both stocks should be evaluated in the context of your investment goals, risk tolerance, and portfolio diversification needs.